Type ? Target B7-H3 CAS Number 1353485-38-7 | Source Humanized (from mouse) ATC code none ChemSpider none | |
Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators.
This drug was developed by MacroGenics, Inc.
References
Enoblituzumab Wikipedia(Text) CC BY-SA